Participants will learn about the prevalence, incidence, and economic impact of venous thromboembolism and atrial fibrillation on patients, as well as the associated treatments and clinical data relating to efficacy, safety, and cost-efficacy.
Robert Lavender, MD, FACP
Advertisement
Articles by Robert Lavender, MD, FACP
Advertisement
Latest Updated Articles
- The Impact of Direct Oral Anticoagulants in the Managed Care Environment
December 17th 2015
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care
3
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
4
FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies
5